Millennium Management’s Hemab Therapeutics COAG Stock Holding History
Bought
Maintained
Sold
Other funds holding COAG
SL
Millennium Management's COAG Position: Q3 2026 in Review
Millennium Management opened a new position in Hemab Therapeutics (COAG) in Q3 2026: 11,695 shares worth $361K. The stake represents ﹤0.01% of the portfolio and ranks #5224 among its holdings.
89 funds tracked by Wall St. Rank hold COAG as of Q3 2026.
- Millennium Management held 11,695 shares of Hemab Therapeutics worth $361K as of Q3 2026.
- Hemab Therapeutics was a new Millennium Management position in Q3 2026.
- Hemab Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5224 holding.
- 89 funds tracked by Wall St. Rank held Hemab Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.